Perceptual Training Techniques for Body Dysmorphic Disorder
Trial Summary
Will I have to stop taking my current medications?
Yes, participants must be medication-free for at least 8 weeks before joining the trial, except for certain short-term medications for insomnia or anxiety, which have specific usage limits.
What data supports the effectiveness of the treatment for Body Dysmorphic Disorder?
Research suggests that treatments focusing on visual attention and perception, like perceptual retraining, may help improve symptoms of Body Dysmorphic Disorder (BDD). Studies show that modifying visual attention can enhance brain connectivity and reduce symptom severity, indicating potential benefits for BDD treatment.12345
Is perceptual training for body dysmorphic disorder safe for humans?
How does perceptual training differ from other treatments for body dysmorphic disorder?
Perceptual training for body dysmorphic disorder is unique because it focuses on modifying visual attention and processing biases, which are core issues in the disorder. Unlike traditional treatments like cognitive behavioral therapy or medication, this approach aims to retrain how individuals visually perceive themselves, potentially improving holistic visual processing and reducing attention to perceived flaws.14578
What is the purpose of this trial?
A core symptom of body dysmorphic disorder (BDD) is perceptual distortions for appearance, which contributes to poor insight and delusionality, limits engagement in treatment, and puts individuals at risk for relapse. Results from this study will provide a comprehensive mechanistic model of brain, behavioral, and emotional contributors to abnormal perceptual processing, as well as how malleable it is with visual modulation techniques. This will lay the groundwork for next-step translational perceptual retraining approaches.
Research Team
Jamie D Feusner, M.D.
Principal Investigator
Centre for Addiction and Mental Health
Eligibility Criteria
This trial is for individuals aged 18-40 with Body Dysmorphic Disorder (BDD) or subclinical BDD, focused on facial concerns. Participants must meet specific criteria on the Dysmorphic Concern Questionnaire and be medication-free for at least 8 weeks. Healthy controls with low scores on the same questionnaire can also join. Exclusions include other major mental disorders, current psychotherapy, neurological issues, pregnancy, certain medical conditions affecting brain function, and visual acuity worse than 20/35.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including fMRI, eye-tracking, and emotional valence measurements
Treatment
Participants receive visual modulation techniques to assess changes in perceptual functioning and brain activity
Follow-up
Participants are monitored for changes in perceptual functioning and brain activity post-treatment
Treatment Details
Interventions
- attentional modulation
- naturalistic viewing
- perceptual modulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre for Addiction and Mental Health
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
University of Toronto
Collaborator
University of Alabama at Birmingham
Collaborator